GlassScriptPhysician profile
James W Kriegshauser
NPI 1477547453
$7,268.35
in general payments reported to CMS, 2019-2025
44 companies · $1,690 in 2025
The $1,690 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $244 · 2021: $918 · 2022: $781 · 2023: $1,656 · 2024: $1,664 · 2025: $1,690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,010.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,009.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $908.99 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $840.40 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $734.02 | 2020-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $667.62 | 2019-2025 | Evenity, Repatha, Otezla |
| Glaxosmithkline, LLC. | $561.43 | 2021-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Novartis Pharmaceuticals Corporation | $467.02 | 2019-2025 | |
| Pfizer INC. | $443.82 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $308.26 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Exact Sciences Corporation | $248.03 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $230.71 | 2021-2025 | Freestyle Libre 3 |
| Mylan Specialty L.P. | $201.52 | 2021-2024 | Yupelri |
| Amarin Pharma, INC. | $180.24 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $159.31 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $142.29 | 2019 | |
| Phathom Pharmaceuticals, INC. | $93.68 | 2024-2025 | Voquezna |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kriegshauser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.